Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
4.380
+0.690 (18.70%)
At close: Oct 8, 2025, 4:00 PM EDT
4.220
-0.160 (-3.65%)
After-hours: Oct 8, 2025, 7:56 PM EDT
Indaptus Therapeutics Employees
Indaptus Therapeutics had 7 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,423,062
Market Cap
4.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7 | 0 | - |
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | 5 | 3 | 150.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INDP News
- 4 weeks ago - Indaptus Therapeutics Provides Clinical Update - GlobeNewsWire
- 5 weeks ago - Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants - GlobeNewsWire
- 3 months ago - Indaptus Therapeutics Announces Reverse Stock Split - GlobeNewsWire
- 4 months ago - Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants - GlobeNewsWire
- 4 months ago - Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire